Advancing Computerized Cognitive Training for MCI and Alzheimer's Disease in a Pandemic and Post-pandemic World

by Kaylee A. Bodner, Terry E. Goldberg, Terry E. Goldberg, D. P. Devanand, D. P. Devanand, P. Murali Doraiswamy
Published 2020-11-01

Association of APOE e2 genotype with Alzheimer’s and non-Alzheimer’s neurodegenerative pathologies

by Terry E. Goldberg, Edward D. Huey, D. P. Devanand
Published 2020-09-01

A Two-Study Comparison of Clinical and MRI Markers of Transition from Mild Cognitive Impairment to Alzheimer’s Disease

by D. P. Devanand, Xinhua Liu, Patrick J. Brown, Edward D. Huey, Yaakov Stern, Gregory H. Pelton
Published 2012-01-01

The benefits and costs of changing treatment technique in electroconvulsive therapy due to insufficient improvement of a major depressive episode

by Harold A. Sackeim, Joan Prudic, D.P. Devanand, Mitchell S. Nobler, Roger F. Haskett, Benoit H. Mulsant, Peter B. Rosenquist, William V. McCall
Published 2020-09-01

Brain Amyloid Deposition and Longitudinal Cognitive Decline in Nondemented Older Subjects: Results from a Multi-Ethnic Population.

by Yian Gu, Qolamreza R Razlighi, Laura B Zahodne, Sarah C Janicki, Masanori Ichise, Jennifer J Manly, D P Devanand, Adam M Brickman, Nicole Schupf, Richard Mayeux, Yaakov Stern
Published 2015-01-01

A Feasibility Study of a New Method for Electrically Producing Seizures in Man: Focal Electrically Administered Seizure Therapy [FEAST]

by Ziad Nahas, Baron Short, Carol Burns, Melanie Archer, Matthew Schmidt, Joan Prudic, Mitchell S. Nobler, D.P. Devanand, Linda Fitzsimons, Sarah H. Lisanby, Nancy Payne, Tarique Perera, Mark S. George, Harold A. Sackeim
Published 2013-05-01

Antiviral therapy: Valacyclovir Treatment of Alzheimer’s Disease (VALAD) Trial: protocol for a randomised, double-blind,placebo-controlled, treatment trial

by Howard Andrews, D P Devanand, William C Kreisl, Qolamreza Razlighi, Anne Gershon, Yaakov Stern, Akiva Mintz, Thomas Wisniewski, Edward Acosta, Julianna Pollina, Mariasofia Katsikoumbas, Karen L Bell, Gregory H Pelton, Deborah Deliyannides, K M Prasad
Published 2020-02-01

Effects of pulse width and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy

by Harold A. Sackeim, PhD, Joan Prudic, MD, Mitchell S. Nobler, MD, Linda Fitzsimons, RN, Sarah H. Lisanby, MD, Nancy Payne, CSW, Robert M. Berman, MD, PhD, Eva-Lotta Brakemeier, MA, Tarique Perera, MD, D.P. Devanand, MD
Published 2008-04-01

Changes in QTc interval in the citalopram for agitation in Alzheimer's disease (CitAD) randomized trial.

by Lea T Drye, David Spragg, D P Devanand, Constantine Frangakis, Christopher Marano, Curtis L Meinert, Jacobo E Mintzer, Cynthia A Munro, Gregory Pelton, Bruce G Pollock, Anton P Porsteinsson, Peter V Rabins, Paul B Rosenberg, Lon S Schneider, David M Shade, Daniel Weintraub, Jerome Yesavage, Constantine G Lyketsos, CitAD Research Group
Published 2014-01-01